Does NIVOLUMAB Cause Dermatitis bullous? 103 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 103 reports of Dermatitis bullous have been filed in association with NIVOLUMAB (OPDIVO). This represents 0.1% of all adverse event reports for NIVOLUMAB.
103
Reports of Dermatitis bullous with NIVOLUMAB
0.1%
of all NIVOLUMAB reports
10
Deaths
55
Hospitalizations
How Dangerous Is Dermatitis bullous From NIVOLUMAB?
Of the 103 reports, 10 (9.7%) resulted in death, 55 (53.4%) required hospitalization, and 12 (11.7%) were considered life-threatening.
Is Dermatitis bullous Listed in the Official Label?
Yes, Dermatitis bullous is listed as a known adverse reaction in the official FDA drug label for NIVOLUMAB.
What Other Side Effects Does NIVOLUMAB Cause?
Death (11,216)
Malignant neoplasm progression (9,363)
Off label use (5,208)
Diarrhoea (4,692)
Fatigue (3,709)
Pyrexia (3,454)
Intentional product use issue (3,297)
Rash (2,816)
Nausea (2,805)
Decreased appetite (2,619)
What Other Drugs Cause Dermatitis bullous?
LINAGLIPTIN (275)
ACETAMINOPHEN (157)
IBUPROFEN (142)
FUROSEMIDE (140)
PEMBROLIZUMAB (136)
METHOTREXATE (129)
VANCOMYCIN (115)
CARBOPLATIN (105)
ESOMEPRAZOLE (103)
AMOXICILLIN (100)
Which NIVOLUMAB Alternatives Have Lower Dermatitis bullous Risk?
NIVOLUMAB vs NIVOLUMAB\RELATLIMAB-RMBW
NIVOLUMAB vs NIZATIDINE
NIVOLUMAB vs NOMEGESTROL
NIVOLUMAB vs NORDAZEPAM
NIVOLUMAB vs NOREPINEPHRINE